Proteoglycans decorin and biglycan differentially modulate TGF-β-mediated fibrotic responses in the lung
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Transforming growth factor (TGF)-β is a key cytokine in the pathogenesis of pulmonary fibrosis, and pharmacological interference with TGF-β can ameliorate the fibrotic tissue response. The small proteoglycans decorin and biglycan are able to bind and inhibit TGF-β activity in vitro. Although decorin has anti-TGF-β properties in vivo, little is known about the physiological role of biglycan in vivo. Adenoviral gene transfer was used to overexpress active TGF-β, decorin, and biglycan in cell culture and in murine lungs. Both proteoglycans were able to interfere with TGF-β bioactivity in vitro in a dose-dependant manner. In vivo, overexpression of TGF-β resulted in marked lung fibrosis, which was significantly reduced by concomitant overexpression of decorin. Biglycan, however, had no significant effect on lung fibrosis induced by TGF-β. The data suggest that differences in tissue distribution are responsible for the different effects on TGF-β bioactivity in vivo, indicating that decorin, but not biglycan, has potential therapeutic value in fibrotic disorders of the lung.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
Iozzo, R. V. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.609 · Cited by 1,637
Negative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility
Danielson, K. G., Baribault, H., Holmes, D. F., Graham, H., Kadler, K. E., & Iozzo, R. V. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.3.729 · Cited by 1,406
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Self-citationHildebrand, A., Romarís, M., Rasmussen, L. M., Heinegård, D., Twardzik, D. R., Border, W. A., & Ruoslahti, E. (1994) · Biochemical Journal · doi:10.1042/bj3020527 · Cited by 994
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
Border, W. A., Okuda, S., Languino, L. R., Sporn, M. B., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346371a0 · Cited by 988
Abe, M., Harpel, J. G., Metz, C. N., Nunes, I., Loskutoff, D. J., & Rifkin, D. B. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1042 · Cited by 757 · cited 1×
“Bioactive TGF-b was detected using an established bioassay (1).”
MethodBett, A. J., Haddara, W., Prevec, L., & Graham, F. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8802 · Cited by 744
Bianco, P., Fisher, L. W., Young, M. F., Termine, J. D., & Robey, P. G. (1990) · Journal of Histochemistry & Cytochemistry · doi:10.1177/38.11.2212616 · Cited by 666
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
Isaka, Y., Brees, D. K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N. A., & Border, W. A. (1996) · Nature Medicine · doi:10.1038/nm0496-418 · Cited by 482
Giri, S. N., Hyde, D. M., & Hollinger, M. A. (1993) · Thorax · doi:10.1136/thx.48.10.959 · Cited by 402
Interaction of Biglycan with Type I Collagen
Schönherr, E., Witsch-Prehm, P., Harrach, B., Robenek, H., Rauterberg, J., & Kresse, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2776 · Cited by 386
Pulmonary fibrosis: cytokines in the balance
Coker, R., & Laurent, G. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11061218 · Cited by 267
Transient Transgene Expression of Decorin in the Lung Reduces the Fibrotic Response to Bleomycin
KOLB, M., MARGETTS, P. J., GALT, T., SIME, P. J., XING, Z., SCHMIDT, M., & GAULDIE, J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.3.2006084 · Cited by 189
Self-citationAntifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis
Giri, S. N., Hyde, D. M., Braun, R. K., Gaarde, W., Harper, J. R., & Pierschbacher, M. D. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00343-2 · Cited by 180
Pharmacological Therapy for Idiopathic Pulmonary Fibrosis: Past, Present, and Future
Mason, R. J., Schwarz, M. I., Hunninghake, G. W., & Musson, R. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9903009 · Cited by 142
Interstitial fibrosis and growth factors.
Lasky, J. A., & Brody, A. R. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s4751 · Cited by 128
Pathogenesis of lung fibrosis and potential new therapeutic strategies.
McAnulty, R. J., & Laurent, G. J. (1995) · PubMed · Cited by 81
Alterations in Large and Small Proteoglycans in Bleomycin-Induced Pulmonary Fibrosis in Rats
Venkatesan, N., Ebihara, T., Roughley, P. J., & Ludwig, M. S. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.6.9909098 · Cited by 76
Cytokines and pulmonary inflammatory and immune diseases.
Xing, Z., Jordana, M., Gauldie, J., & Wang, J. (1999) · PubMed · doi:10.14670/hh-14.185 · Cited by 32
Self-citationChemoattractants in Fibrotic Disorders
Grotendorst, G. R., Paglia, L. M., Mcivor, C., Barsky, S. H., Martinet, Y., & Pencev, D. (1985) · Novartis Foundation symposium · doi:10.1002/9780470720950.ch10 · Cited by 22
Sime, P. J., Särnstrand, B., Xing, Z., Graham, F. L., Fisher, L. W., & Gauldie, J. (1997) · CHEST Journal · doi:10.1378/chest.111.6_supplement.137s · Cited by 17
Self-citation
Cited by
Extracellular matrix structure
Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598
“Biglycan binds TGF-β and modulates its activity [75] but in contrast to decorin acts as pro-angiogenic”
BackgroundProteoglycan form and function: A comprehensive nomenclature of proteoglycans
Iozzo, R. V., & Schaefer, L. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.003 · Cited by 1,263
TGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI
Khan, T., Muise, E. S., Iyengar, P., Wang, Z. V., Chandalia, M., Abate, N., Zhang, B. B., Bonaldo, P., Chua, S., & Scherer, P. E. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01300-08 · Cited by 1,053
“These genes have a major involvement in the epithelial-mesenchyme transition that occurs during fibro-sis, a process during which epithelial cells differentiate and take on a more mesenchyme-like morphology (30, 46).”
An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics
Angelidis, I., Simon, L. M., Fernandez, I. E., Strunz, M., Mayr, C. H., Greiffo, F. R., Tsitsiridis, G., Ansari, M., Graf, E., Strom, T.-M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08831-9 · Cited by 637
Metadata
- Authors
- Kolb, M., Margetts, P. J., Sime, P. J., & Gauldie, J.
- Venue
- American Journal of Physiology-Lung Cellular and Molecular Physiology
- Publisher
- American Physiological Society
- Published
- 2001-06-01
- Volume
- 280
- Issue
- 6
- Pages
- L1327-L1334
- ISSN
- 1040-0605 (ISSN-L)
- 1522-1504
- OpenAlex
- W2284692617
- Cited by
- 270
- References
- 23
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.